tiprankstipranks
Trending News
More News >
Xbrane Biopharma AB (DE:7XB)
:7XB
Germany Market

Xbrane Biopharma AB (7XB) Income Statement

Compare
2 Followers

Xbrane Biopharma AB Income Statement

Last quarter (Q4 2024), Xbrane Biopharma AB's total revenue was kr65.90M, a decrease of -1.49% from the same quarter last year. In Q4, Xbrane Biopharma AB's net income was kr-53.20M. See Xbrane Biopharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 198.70Mkr 238.73Mkr 57.62Mkr 11.53Mkr 6.82M
Gross Profit
kr 180.47Mkr 35.39Mkr 41.04Mkr -684.00Kkr 2.45M
Operating Expenses
kr 398.40Mkr 357.55Mkr 210.27Mkr 191.93Mkr 231.07M
Depreciation and Amortization
kr 35.95Mkr 21.43Mkr 16.58Mkr 12.22Mkr 4.37M
EBITDA
kr -181.97Mkr -282.03Mkr -149.34Mkr -167.59Mkr -213.07M
Operating Income
kr -217.92Mkr -310.43Mkr -166.22Mkr -180.40Mkr -224.25M
Other Income/Expenses
kr -35.51Mkr -11.60Mkr -2.30Mkr -2.64Mkr -690.00K
Pretax Income
kr -253.43Mkr -322.03Mkr -168.51Mkr -183.23Mkr -226.03M
Net Income
kr -266.22Mkr -388.17Mkr -172.23Mkr -191.01Mkr -226.79M
Per Share Metrics
Basic EPS
kr -0.17kr -1.27kr -0.77kr -0.90kr -1.41
Diluted EPS
kr -0.17kr -1.27kr -0.77kr -0.90kr -1.41
Weighted Average Shares Outstanding
1.53B 253.21M 225.55M 208.11M 159.78M
Weighted Average Shares Outstanding (Diluted)
1.53B 253.21M 225.55M 208.11M 159.78M
Currency in SEK

Xbrane Biopharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis